Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine
E
E
Service de Néphrologie, Hôpital Nord, Saint-Etienne, France.
Berthoux
F
F
Acquart
S
S
Lepetit
J C
JC
D002102:Cadaver; D016572:Cyclosporine / Q000008:administration & dosage; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology*; D015234:HLA-A Antigens / Q000235:genetics / Q000276:immunology; D015235:HLA-B Antigens / Q000235:genetics / Q000276:immunology; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D010641:Phenotype; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality; D012086:Reoperation; D012189:Retrospective Studies; D016019:Survival Analysis; D015996:Survival Rate
D006680:HLA Antigens; D015234:HLA-A Antigens; C043205:HLA-A19 antigen; D015235:HLA-B Antigens; C063569:HLA-B21 antigen; D006684:HLA-DR Antigens; C043263:HLA-DRw10; D016572:Cyclosporine